Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Indexes  >  Australian Stock Exchange  >  S&P/ASX 200    XJO   XC0006013624

S&P/ASX 200

SummaryMost relevantAll NewsNews of the index componentsMarketScreener Strategies

Australia shares drop as vaccine trials halt, stimulus hopes fade

10/14/2020 | 01:52am EST

* Johnson & Johnson pauses COVID-19 vaccine trials

* Impasse in U.S. fiscal aid package talks sours sentiment

* Lower oil prices hurt Australian energy stocks

Oct 14 (Reuters) - Australian shares closed lower on Wednesday, with heavy selling in financial and energy stocks, as halted COVID-19 vaccine trials and an elusive U.S. coronavirus relief package dented risk appetite.

The S&P/ASX 200 index slipped 0.3% to 6,179.20 at the close of trade. The benchmark closed 1% higher on Tuesday.

Global markets took cue as major indexes on Wall Street closed the previous session in the red, after COVID-19 vaccine trials were paused by Johnson & Johnson due to an unexplained illness in a study participant.

Diminishing hopes for the passage of a U.S. coronavirus relief bill also added to the gloom after House Speaker Nancy Pelosi rejected the $1.8 trillion proposal from the White House.

"It's (U.S. stimulus) become a fairly politically charged event, and I'm not sure that the Democrats are going to give Mr. Trump a free kick and pass anything stimulus wise for the next 20 days," said Damian Rooney, director of equity sales at Argonaut.

The heavyweight financial sector stocks finished about 1% lower, with the so-called "Big Four" banks closing in the red.

"Few brokers are starting to look at the banking sector after its big run, so I think there's a few profit takers there," Henry Jennings, a senior analyst and portfolio manager at Marcustoday said.

Energy stocks slid 0.9% at close, after oil prices slipped, with Woodside Petroleum easing 1.2% and Oil Search losing 1.7%.

Limiting losses, the healthcare sector advanced 1.3%, with the help of CSL Ltd's 1.4% gain and Sonic Healthcare closing 2.3% firmer.

CSL lifted its FY2021 net profit to be between $2.17 bln and $2.27 bln at constant currency, compared with its initial forecast of $2.10 bln to $2.27 bln

Meanwhile, Sonic Healthcare marked its highest close after reporting first-quarter core earnings of A$580 million, up from A$340 million last year.

In New Zealand, the benchmark S&P/NZX 50 index rose 0.72% to yet another closing high of 12,543.61.

Top gainers were Mainfreight Ltd, up 5.77%, followed by EBOS Group Ltd, gaining 3.46%. (Reporting by Nikhil Subba in Bengaluru, Editing by Sherry Jacob-Phillips)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
CSL LIMITED -1.85% 297.38 End-of-day quote.7.84%
EBOS GROUP LIMITED 1.16% 25.19 End-of-day quote.3.88%
LONDON BRENT OIL -0.80% 47.34 Delayed Quote.-27.86%
MAINFREIGHT LIMITED -2.20% 61.02 End-of-day quote.43.58%
S&P/ASX 200 1.08% 6588.5 Real-time Quote.-2.49%
SONIC HEALTHCARE LIMITED -0.96% 32.94 End-of-day quote.14.57%
WHITEHAVEN COAL LIMITED -9.56% 1.325 End-of-day quote.-49.81%
WOODSIDE PETROLEUM LTD -1.58% 22.37 End-of-day quote.-34.93%
WORLEY LIMITED -0.54% 12.9 End-of-day quote.-15.74%
WTI -1.50% 44.55 Delayed Quote.-26.43%
All news about S&P/ASX 200
12:43aAustralian shares jump 1% as cenbank holds rates on housing market boom
11/30Asian shares open higher following stellar month of gains
11/30Australia shares recover ground ahead of cenbank decision; China tensions wei..
11/30Greatland Gold, Newcrest Mining Extend Collaboration in Australian Gold Proje..
11/30TREASURY WINE ESTATES : Australian stocks drop on China tensions; post record mo..
11/29TREASURY WINE ESTATES : Australia shares eye record monthly gain on vaccine chee..
11/27Australia shares end lower as vaccine doubts weigh
11/26Vaccine optimism sets Australia shares for best month on record
11/26Australia, NZ shares slip as investors shun risk on bleak U.S. jobs data
11/25Australia shares trade flat as gloomy U.S. jobs data blunts vaccine cheer
More news
News of the index components S&P/ASX 200
12:03pSOUTH32 : Securities Dealing Policy
12:03pSOUTH32 : ASIC Form 484 cancellation of on-market buy-back shares
08:38aTurquoise Hill says special committee to review Oyu Tolgoi cost overruns
04:58aBHP : announces early redemption of hybrid securities | BHP
04:27aWESTPAC BANKING : APRA Review of Risk Governance and breach of Liquidity
03:59aAMPOL : Appendix 3B
More news
Chart S&P/ASX 200
Duration : Period :
S&P/ASX 200 Technical Analysis Chart | XJO | XC0006013624 | MarketScreener
Technical analysis trends S&P/ASX 200
Short TermMid-TermLong Term
Heatmap :